This site is intended for US Healthcare Professionals

CKD progression in T2D destroys kidneys

INFLAMMATION
AND FIBROSIS

ARE DESTROYING YOUR
PATIENTS’ KIDNEYS

Disrupt the current thinking about chronic kidney disease (CKD) progression in type 2 diabetes (T2D)

Even with HbA1c and blood pressure under control, CKD patients with T2D still face kidney damage due to inflammation and fibrosis, a largely unaddressed and major cause of CKD progression.1-3

3 drivers include inflammation and fibrosis

Inflammation and fibrosis is one of 3 main drivers of CKD progression1

Learn More
Watch video about what drives CKD progression

Watch how inflammation and fibrosis are triggered by mineralocorticoid receptor overactivation4

Watch Video

Unaddressed inflammation and fibrosis in CKD patients with T2D can lead to CKD progression, end-stage kidney disease, and increased cardiovascular risk.1,3,4

Don’t miss the latest information about CKD in T2D

Sign Up for Updates

References:

  • Alicic RZ, Rooney MT, Tuttle KR. Clin J Am Soc Nephrol. 2017;12(12):2032-2045.
  • Brenner BM, Cooper ME, De Zeeuw D, et al. N Engl J Med. 2001;345(12):861-869.
  • Perkovic V, Jardine MJ, Neal B, et al. N Engl J Med. 2019;380(24):2295-2306.
  • Bauersachs J, Jaisser F, Toto R. Hypertension. 2015;65(2):257-263.